Much like the biological systems it explores, the US biotechnology ind
ustry has mechanisms that allow it to change in response to its enviro
nment, Terms such as 'consolidation', 'downsizing' and 'restructuring'
that were once only used in the context of larger corporations, are n
ow being used to describe the industrial evolution of biotechnology. B
ut exactly how have these changes affected the industry; how are the m
ajority of biotechnology firms faring; what are the different areas of
interest for R & D, and how do these sectors vary; and, how does the
current structure of the industry affect the future?.